Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China · Delayed Price · Currency is CNY 21.05
+0.42 (2.04%)
May 29, 2026, 3:04 PM CST
SHE:002287 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 667.92 | 648.43 | 582.28 | 581.2 | 472.54 | 715.88 |
Depreciation & Amortization | 141.75 | 141.75 | 139.34 | 93.24 | 83.19 | 65.83 |
Other Amortization | 0.92 | 0.92 | 1.03 | 2.53 | 2.72 | 2.08 |
Loss (Gain) From Sale of Assets | -7.38 | -7.38 | - | -0.32 | -0 | 0.07 |
Asset Writedown & Restructuring Costs | -0.06 | -0.06 | 0.58 | 0.3 | 1.22 | 16.13 |
Loss (Gain) From Sale of Investments | -68.09 | -68.09 | -100.32 | -69.31 | 32.86 | -328.81 |
Provision & Write-off of Bad Debts | -0.74 | -0.74 | 0.16 | 0.38 | 0.74 | -1.36 |
Other Operating Activities | -400.86 | 37.94 | 57.82 | 61.84 | 54.9 | 48.66 |
Change in Accounts Receivable | 12.29 | 12.29 | -278.79 | 41.95 | -209.3 | 369.7 |
Change in Inventory | -109.02 | -109.02 | -29.72 | -28.46 | -10.65 | -24.04 |
Change in Accounts Payable | 80.75 | 80.75 | 75.67 | 9.79 | -146.43 | 136.6 |
Change in Other Net Operating Assets | -0.06 | -0.06 | - | 24.51 | 12.38 | -4.61 |
Operating Cash Flow | 310.41 | 729.7 | 456.75 | 693.41 | 285.69 | 1,035 |
Operating Cash Flow Growth | -65.66% | 59.76% | -34.13% | 142.72% | -72.39% | 335.44% |
Capital Expenditures | -125.06 | -153.08 | -255.44 | -234.81 | -272.4 | -125.57 |
Sale of Property, Plant & Equipment | 0.39 | 0.39 | - | 0.04 | - | 0 |
Cash Acquisitions | - | - | - | - | - | -61.11 |
Investment in Securities | 57.84 | 99.45 | -333.78 | -354.28 | -92.56 | -1,984 |
Other Investing Activities | 57.31 | 74.23 | 71.21 | 278.47 | 30.46 | 14.98 |
Investing Cash Flow | -9.52 | 20.99 | -518.02 | -310.59 | -334.5 | -2,155 |
Long-Term Debt Issued | - | 961.58 | 811.87 | 750 | 806.39 | 500 |
Total Debt Issued | 842.83 | 961.58 | 811.87 | 750 | 806.39 | 500 |
Long-Term Debt Repaid | - | -936.36 | -667.63 | -961.85 | -645.26 | -347.38 |
Total Debt Repaid | -1,036 | -936.36 | -667.63 | -961.85 | -645.26 | -347.38 |
Net Debt Issued (Repaid) | -193.6 | 25.21 | 144.24 | -211.85 | 161.13 | 152.62 |
Issuance of Common Stock | - | - | - | - | - | 0.16 |
Repurchase of Common Stock | -137.45 | -137.45 | - | - | - | - |
Common Dividends Paid | -339.54 | -453.04 | -282.45 | -220.05 | -340.51 | -195.54 |
Other Financing Activities | 2.52 | 1.2 | - | -0.6 | -3.84 | - |
Financing Cash Flow | -668.07 | -564.08 | -138.21 | -432.5 | -183.22 | -42.76 |
Foreign Exchange Rate Adjustments | -0.17 | -0.11 | 0.56 | 0.61 | 2.97 | -0.75 |
Net Cash Flow | -367.35 | 186.5 | -198.91 | -49.07 | -229.06 | -1,164 |
Free Cash Flow | 185.35 | 576.63 | 201.31 | 458.59 | 13.29 | 909.35 |
Free Cash Flow Growth | -71.37% | 186.44% | -56.10% | 3350.89% | -98.54% | - |
Free Cash Flow Margin | 7.66% | 23.87% | 8.61% | 22.42% | 0.65% | 51.36% |
Free Cash Flow Per Share | 0.34 | 1.06 | 0.38 | 0.86 | 0.03 | 1.72 |
Cash Income Tax Paid | 375.42 | 354.49 | 333.34 | 284.33 | 243.7 | 270.37 |
Levered Free Cash Flow | -220.92 | 220.17 | -157.58 | 457.62 | -2.83 | 576.99 |
Unlevered Free Cash Flow | -202.77 | 246.33 | -121.46 | 497.04 | 32.43 | 610.38 |
Change in Working Capital | -23.05 | -23.05 | -224.14 | 23.54 | -362.48 | 516.45 |